Function tests and fine-needle aspirations help increase early diagnoses.
Translational research is producing targeted therapies to kill cancer while sparing the patient.
The one-two-three's of classifying benign and malignant blood disorders.
ADVANCE explores using patient data from a population to look for physiological variation.
Enter Your Submissions Now
KEEP UP WITH US ON ...
ADVANCE Extra
Most Popular Content
-
By Glen McDaniel
|
11/18/2009 6:26:43 AM
-
By Rhonda Daily
|
10/27/2009 4:20:00 PM
-
By Scott Warner
|
10/24/2009 10:57:33 AM
-
By Amanda Koehler
|
10/28/2009 1:55:33 PM
-
By Scott Warner
|
11/03/2009 6:32:34 PM
-
By Tiffany Landis
|
11/16/2009 10:05:00 AM
-
By Matthew T. Patton
|
11/20/2009 3:53:00 PM
-
By Amanda Koehler
|
11/11/2009 11:58:00 AM
-
By Scott Warner
|
11/20/2009 6:02:00 AM
-
By Matthew T. Patton
|
11/20/2009 11:14:00 AM
-
11/17/2009 4:38:51 PM
-
11/03/2009 5:53:54 PM
-
11/08/2009 10:21:10 PM
-
By Kerri Penno
|
11/11/2009 1:47:50 PM